Hong Kong Stock Movement | Hengrui Pharmaceuticals (01276.HK) rises nearly 4%; the company repurchases A-shares for the first time; institutions are bullish that the non-oncology segment will continue to contribute product-side incremental growth.
Zhito Finance APP has learned that Hengrui Pharmaceuticals (01276.HK) rose nearly 4%, up 3.2% as of press time, at HK$45.8, with a turnover of HK$59.5373 million.
Latest
